NewAmsterdam Pharma

Home
United States
Aventura, FL
NewAmsterdam Pharma

NewAmsterdam Pharma Corporation is a late-stage clinical biopharma company. Intended for US audiences Intended for US audiences only.

NewAmsterdam Pharma Corporation is a late-stage clinical biopharma company developing therapies for cardiometabolic diseases.

08/19/2025

Lowering LDL-C is about reducing the risk of heart attacks, strokes, and the need for costly interventions – not just hitting a target.

Dr. Maya Safarova explains why goal attainment should be the standard, not the exception.

👇 Learn about the limitations of current lipid-lowering therapies.
https://bit.ly/41GZ1KI

08/14/2025

Did you know cholesterol plays a critical role in brain health? While it’s essential, too much or poorly regulated cholesterol can contribute to the buildup of amyloid plaque and tau tangles, key markers of Alzheimer’s disease.

Explore how cholesterol works in the brain: https://bit.ly/45OQTu2

08/07/2025

A growing body of research indicates CETP plays a central role in both systemic and brain lipid metabolism. Genetic studies show those with naturally low CETP levels are at a lower risk of Alzheimer’s disease, particularly in ApoE4 carriers. Learn more about this emerging link: https://www.newamsterdampharma.com/lipid-related-conditions/?utm_source=fb&utm_medium=organic&utm_campaign=other-conditions

08/04/2025

p-Tau217 is emerging as an important biomarker that can be used to help diagnose and monitor Alzheimer’s disease progression. It’s also one of the core components of the first blood-based diagnostic test for the disease.

Learn more about p-Tau217 and why it’s important to our research.
https://bit.ly/451rFbB

07/30/2025

NEW at : Data from a prespecified analysis from our BROADWAY trial support the emerging link between CETP inhibition and Alzheimer’s disease pathology. Take a closer look at the data: https://bit.ly/4l5K5gb

07/15/2025

Reducing high cholesterol is one important part of managing your heart health, but as our Chief Scientific Officer Dr. John Kastelein explains, residual risk factors may also need to be addressed. Learn more about these additional factors: https://bit.ly/3GLk3Ra

06/26/2025

Lowering LDL-C isn’t just about the numbers—it’s about protecting your health. Even small reductions can make a meaningful difference in lowering your risk of heart attack or stroke.

Learn more about the benefits of LDL-C reduction: https://bit.ly/3GgTNOj

06/12/2025

We wrapped up an energizing R&D Day with a bang, a bell, and confetti as our team gathered around the podium to bring trading to a close. This is the enthusiasm we’re bringing to our work to advance a new era of treatment for cardiovascular disease and other lipid-related conditions.

06/05/2025

Statins are an important tool for lowering cholesterol, but they can also trigger diabetes progression.

A retrospective study of over 83,000 patients with diabetes found that statin use was linked to a 37% higher risk of worsening diabetes.

That’s why we need innovative treatment options that lower cholesterol without additional risk.

https://bit.ly/45FSSkK

05/30/2025

We’re excited to see data from our Phase 3 BROADWAY study shared in a late-breaking oral presentation at NLA Sessions. Discover what we’ve learned in this study of 2,500 patients at high risk for cardiovascular disease. https://bit.ly/4jtnM3d

05/21/2025

Heart disease remains the leading cause of death for women worldwide. The Journal of the American College of Cardiology explores ways we can address the global burden of heart disease in women, highlighting the need for improved awareness, research, and tailored prevention efforts. https://bit.ly/4jfrQUu

05/19/2025

1 in 4 U.S. adults—over 63 million people—have high LDL-C, a key driver of cardiovascular disease. Managing cholesterol isn’t just about numbers—it’s about taking action to reduce your risk of a cardiovascular event.

Learn more about why LDL-C control matters and what you can do: https://bit.ly/NewAmExpectMore

Address

Aventura, FL

Website

https://www.newamsterdampharma.com/

Alerts

Be the first to know and let us send you an email when NewAmsterdam Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Aventura?